CWM
LYRA

CIBC World Markets’s LYRA THERAPEUTICS INC LYRA Stock Holding History

CIBC World Markets’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-215
Closed -$1.36K – 1774
2025
Q1 		$1.36K Buy
+215
New +$2.01K ﹤0.01% 1841

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC World Markets's LYRA Position: Q2 2025 in Review

CIBC World Markets sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 215 shares — an estimated $1.36K sold.

CIBC World Markets first reported a position in LYRA in Q1 2025 and held it in 1 quarter. The position peaked at $1.36K in Q1 2025. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • CIBC World Markets reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 215 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $1.36K.
  • CIBC World Markets first reported a position in LYRA THERAPEUTICS INC in Q1 2025 and held it in 1 quarter.
  • CIBC World Markets's LYRA THERAPEUTICS INC position peaked at $1.36K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.